Back to Search
Start Over
Estimation of withdrawal interval recommendations following administration of fenbendazole medicated feed to ring-necked pheasants ( Phasianus colchicus ).
- Source :
-
Frontiers in veterinary science [Front Vet Sci] 2024 Jul 31; Vol. 11, pp. 1444009. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Introduction: Prescribing fenbendazole medicated feed for pheasants in the USA is considered extra-label drug use under CPG Sec 615.115, and a safe estimated withdrawal interval (WDI) must be applied following administration to this minor food-producing species. This study sought to determine the pharmacokinetic and residue depletion profile for fenbendazole and its major metabolites to estimate a WDI for pheasants following fenbendazole administration as an oral medicated feed.<br />Method: Pheasants ( n = 32) were administered fenbendazole as an oral medicated feed (100 ppm) for 7 days. Fenbendazole, fenbendazole sulfoxide, and fenbendazole sulfone (FBZ-SO <subscript>2</subscript> ) in liver and muscle samples were analyzed using HPLC-UV. Tissue WDIs were estimated using FDA, European Medicines Agency (EMA), and half-life multiplication methods for US poultry tolerances, EMA maximum residue limits, and the analytical limit of detection (LOD; 0.004 ppm). Terminal tissue elimination half-lives (T <subscript>1/2</subscript> ) were estimated by non-compartmental analysis using a naïve pooled data approach.<br />Results: The tissue T <subscript>1/2</subscript> was 14.4 h for liver, 13.2 h for thigh muscle, and 14.1 h for pectoral muscle. The maximum estimated withdrawal interval was 153 h (7 days) for FBZ-SO <subscript>2</subscript> in pectoral muscle using the FDA tolerance method (95% confidence interval for the 99 <superscript>th</superscript> percentile of the population), and the LOD as the residue limit.<br />Discussion: The results from this study support the use of FBZ-SO <subscript>2</subscript> as the marker residue in the liver of pheasants and the provision of evidence based WDIs following the extra-label administration of fenbendazole medicated feed (100 ppm) for 7 days.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Carreño Gútiez, Mercer, Martínez-López, Griffith, Wetzlich and Tell.)
Details
- Language :
- English
- ISSN :
- 2297-1769
- Volume :
- 11
- Database :
- MEDLINE
- Journal :
- Frontiers in veterinary science
- Publication Type :
- Academic Journal
- Accession number :
- 39144087
- Full Text :
- https://doi.org/10.3389/fvets.2024.1444009